Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Compound Heterozygosity for Hb S and a Novel Deletion of Dnase I Hypersensitivity Sites HS3 and HS4 of β-Globin Locus Control Region Results in Hb S/β + -Thalassemia Phenotype

Ali Amid, MD, Barry Eng, BSc, Betty-Ann Hohenadel, BSc, Meredith Hanna, BSc, Lisa N. Nakamura, BSc, Lynda Walker, MLT, Melina Cheong, RN, BSc, Melanie Kirby-Allen, MBBS, John S. Waye, PhD

Blood (2014) 124 (21): 2692.

https://doi.org/10.1182/blood.V124.21.2692.2692

Published: 2014

Journal Articles

Retrospective Evaluation of Patients Referred for Hemochromatosis Genetic Testing

Matthew B. Lanktree, MD PhD, Bruce B. Lanktree, MD, John S. Waye, PhD, Guillaume Pare, MD MSc, Bekim Sadikovic, PhD, Mark A. Crowther, MD

Blood (2014) 124 (21): 4035.

https://doi.org/10.1182/blood.V124.21.4035.4035

Published: 2014

Journal Articles

Dysregulation of C10orf55 Expression in Megakaryocytic Cell Lineage From Quebec Platelet Disorder Individuals

Natalia Bunimov, PhD, Jessica Blavignac, BSc, Subia Tasneem, PhD, John S Waye, PhD, Andrew D Paterson, MD, Georges E Rivard, MD, Catherine PM Hayward, MD, PhD

Blood (2011) 118 (21): 2274.

https://doi.org/10.1182/blood.V118.21.2274.2274

Published: 2011

Journal Articles

Targeted Gene Sequencing to Identify Polymorphisms in the Protein C and EPCR Genes in Patients with Unprovoked Venous Thromboembolism.

Cynthia M Wu, MD, FRCPC, Dhruva J Dwivedi, PhD, Wasifa Zarin, Zakhar Lysov, BSc, John S Waye, PhD, Clive Kearon, MD, MRCPI, FRCPC, PhD, Patricia Liaw, PhD

Blood (2009) 114 (22): 454.

https://doi.org/10.1182/blood.V114.22.454.454

Published: 2009

Journal Articles

Quebec Platelet Disorder Is Caused by a Cis-Acting Mutation near the Plasminogen Activator Gene (PLAU) That Increases PLAU Transcription by Megakaryocytes.

Maria Diamandis, Andrew D Paterson, PhD, Johanna M Rommens, PhD, D. Kika Veljkovic, MD, Jessica Blavignac, John S Waye, PhD, Francine Derome, Georges E. Rivard, MD, Catherine PM Hayward, MD, PhD

Blood (2008) 112 (11): 3394.

https://doi.org/10.1182/blood.V112.11.3394.3394

Published: 2008

NARROW

Compound Heterozygosity for Hb S and a Novel Deletion of Dnase I Hypersensitivity Sites HS3 and HS4 of β-Globin Locus Control Region Results in Hb S/β + -Thalassemia Phenotype

Retrospective Evaluation of Patients Referred for Hemochromatosis Genetic Testing

Dysregulation of C10orf55 Expression in Megakaryocytic Cell Lineage From Quebec Platelet Disorder Individuals

Targeted Gene Sequencing to Identify Polymorphisms in the Protein C and EPCR Genes in Patients with Unprovoked Venous Thromboembolism.

Quebec Platelet Disorder Is Caused by a Cis-Acting Mutation near the Plasminogen Activator Gene (PLAU) That Increases PLAU Transcription by Megakaryocytes.

Email alerts

ASH Publications

American Society of Hematology

Compound Heterozygosity for Hb S and a Novel Deletion of Dnase I Hypersensitivity Sites HS3 and HS4 of β-Globin Locus Control Region Results in Hb S/β + -Thalassemia Phenotype

Retrospective Evaluation of Patients Referred for Hemochromatosis Genetic Testing

Dysregulation of C10orf55 Expression in Megakaryocytic Cell Lineage From Quebec Platelet Disorder Individuals

Targeted Gene Sequencing to Identify Polymorphisms in the Protein C and EPCR Genes in Patients with Unprovoked Venous Thromboembolism.

Quebec Platelet Disorder Is Caused by a Cis-Acting Mutation near the Plasminogen Activator Gene (PLAU) That Increases PLAU Transcription by Megakaryocytes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only